Further hope for BCG vaccine in stemming type 1 diabetes
Researchers presented positive trial updates at the 2021 Annual Scientific Sessions of the American Diabetes Association
2021-06-25
(Press-News.org) BOSTON - At the recent 2021 Annual Scientific Sessions of the American Diabetes Association, researchers from Massachusetts General Hospital (MGH) presented positive updates on their trials of the bacillus Calmette-Guérin (BCG) vaccine to safely and significantly lower blood sugars.
In type 1 diabetes, an autoimmune disease which currently has no cure, T cells attack the pancreas and destroy its ability to create insulin, a hormone vital in allowing glucose to enter cells to produce energy. In prior work, Denise Faustman, MD, PhD, director of the MGH Immunobiology Laboratory, and colleagues have found that BCG boosts a substance called TNF, which eliminates the harmful T cells and aids development of beneficial ones called regulatory T cells, or Tregs.
Key findings include new understanding in how response to BCG vaccination differs depending on a patient's age of onset and additional support for the role of BCG vaccination to alter glucose transport and change Tregs. Currently 143 type 1 diabetics have received at least two doses of BCG, including 25 patients enrolled in a recently launched trial of adults who had pediatric onset. Pending FDA approval, MGH aims to launch a multi-center pediatric trial later this year.
"More data from randomized double-blinded clinical trials will be reported as we move towards additional readout of the Phase II trial," says Faustman, principal investigator of BCG clinical trials at MGH. "We have continued evidence of BCG's ability to reset and restore the immune system."
In 2018 MGH published results of the follow-up of Phase I trial of BCG-treated long-term diabetic participants, showing lasting clinically and statistically significant drops in HbA1c values that persisted with eight years of follow-up. The new data presented at the ADA include:
Type 1 diabetics with age of onset younger than 21 years have a faster response time and greater change in HbA1c than adult onset type 1 diabetics.
Over a period of three years BCG returns gene expression in Tregs in type 1 diabetics to a pattern consistent with non-type 1 control subjects.
The HbA1c response at two years in juvenile onset subjects is consistent with the three-year response seen in the Phase 1 study.
"BCG is an old vaccine, but it seems to be presenting new gifts," says Nigel Curtis, MD, PhD, of the Murdoch Children's Research Institute in Melbourne, Australia. He directs global clinical trials on the beneficial and off-targets effects of the BCG vaccine but was not involved in the current study. "This new data from MGH adds the growing understanding of how BCG changes the way the body responds to autoimmune and infectious disease."
INFORMATION:
The MGH team's findings set the stage for the read out of the ongoing five-year phase 2 study currently under way and anticipated to be complete in two years. Additional information about clinical trials is available at http://www.faustmanlab.org or by emailing DiabetesTrial@partners.org.
About the Massachusetts General Hospital
Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The Mass General Research Institute conducts the largest hospital-based research program in the nation, with annual research operations of more than $1 billion and comprises more than 9,500 researchers working across more than 30 institutes, centers and departments. In August 2020, Mass General was named #6 in the U.S. News & World Report list of "America's Best Hospitals."
ELSE PRESS RELEASES FROM THIS DATE:
2021-06-25
A new study by UC Davis researchers confirms the low likelihood that SARS-CoV-2 contamination on hospital surfaces is infectious. END ...
2021-06-25
Scientists from the University of Michigan have developed an innovative way to use NASA satellite data to track the movement of tiny pieces of plastic in the ocean.
Microplastics form when plastic trash in the ocean breaks down from the sun's rays and the motion of ocean waves. These small flecks of plastic are harmful to marine organisms and ecosystems. Microplastics can be carried hundreds or thousands of miles away from the source by ocean currents, making it difficult to track and remove them. Currently, the main source of information about the location ...
2021-06-25
New Rochelle, NY, June 24, 2021—The American Thyroid Association, the European Association of Nuclear Medicine, the European Thyroid Association, and the Society of Nuclear Medicine and Molecular Imaging released a joint statement on three key topics addressing controversies in thyroid cancer care. The joint statement is published in the peer-reviewed journal Thyroid®, the official journal of the American Thyroid Association® (ATA®).Click here to read the statement now.
An inter-societal working group addressed the current controversies and evolving concepts in three main areas: peri-operative risk stratification; the role of diagnostic radioactive iodine ...
2021-06-25
Toronto, ON - Despite research showing associations between anabolic steroid use and criminal offending, the possibility of a similar association between legal performance-enhancing substance use, such as creatine, and criminal offending remained unknown. A new study published online in the journal Drug and Alcohol Dependence now shows that both forms of performance-enhancing substance use is longitudinally associated with criminal offending among U.S. adults.
The study, which analyzed a sample of over 9,000 U.S. participants from the National Longitudinal Study ...
2021-06-25
Liza Makowski, PhD, professor in the Department of Medicine and the UTHSC Center for Cancer Research, has long been interested in how the immune system is altered by obesity and how this impacts cancer risk and treatment.
"Obesity is complex, because it can cause both inflammation and activate counter-inflammation pathways leading to immunosuppression," Dr. Makowski said. "How obesity impacts cancer treatments is understudied."
Obese patients with breast cancer often have worse outcomes than non-obese patients. However, exciting developments are being made in other cancers that may also hold promise for treating breast cancer. In studies of ...
2021-06-25
"Fit for 55": under this heading, the EU Commission will specify the implementation of the European Green Deal on 14 July. This refers to the more ambitious climate policy announced, with 55 instead of 40 percent emission reduction by 2030 (relative to 1990), and net-zero emissions in 2050. Coordination between the 27 EU states is expected to be difficult since unanimity is usually required here for sweeping changes. An economic model study by the Berlin-based climate research institute MCC (Mercator Research Institute on Global Commons and Climate Change) and the Potsdam Institute for Climate Impact Research (PIK) examines how to achieve good results under such conditions. The study has just been published in the renowned Journal of Environmental ...
2021-06-25
New SARS-CoV-2 variants are spreading rapidly, and there are fears that current COVID-19 vaccines won't protect against them. The latest in a series of structural studies of the SARS-CoV-2 variants' "spike" protein, led by Bing Chen, PhD, at Boston Children's Hospital, reveals new properties of the Alpha (formerly U.K.) and Beta (formerly South Africa) variants. Of note, it suggests that current vaccines may be less effective against the Beta variant.
Spike proteins, on the surface of SARS CoV-2, are what enable the virus to attach to and enter our cells, and all current vaccines are directed against them. The new study, published in Science on June 24, used cryo-electron microscopy (cryo-EM) ...
2021-06-25
LA JOLLA, CA--Researchers at La Jolla Institute for Immunology (LJI) have shed light on a process in immune cells that may explain why some people develop cardiovascular diseases.
Their research, published recently in Genome Biology, shows the key role that TET enzymes play in keeping immune cells on a healthy track as they mature. The scientists found that other enzymes do play a role in this process--but TET enzymes do the heavy lifting.
"If we can figure out what's going on with these enzymes, that could be important for controlling cardiovascular disease," ...
2021-06-25
Scientists at Tokyo Institute of Technology design polymers infused with a stress-sensitive molecular unit that respond to external forces by switching on their fluorescence. The researchers demonstrate the fluorescence to be dependent on the magnitude of force and show that it is possible to detect both, reversible and irreversible polymer deformations, opening the door to the exploration of new force regimes in polymers.
Besides causing physical motion, mechanical forces can drive chemical changes in controlled and productive ways, allowing for desirable material properties. One way to go about this is by introducing a so-called mechanophore ...
2021-06-25
Amphiphilic molecules, which aggregate and encapsulate molecules in water, find use in several fields of chemistry. The simple, additive-free connection of hydrophilic and hydrophobic molecules would be an efficient method for amphiphilic molecule synthesis. However, such connections, or bonds, are often fragile in water. Now, scientists at Tokyo Institute of Technology have developed an easy way to prepare water-stable amphiphiles by simple mixing. Their new catalyst- and reagent-free method will help create further functional materials.
Soaps and detergents are used to clean things like clothes and dishes. But how do they actually work? It turns out that they are made of long molecules ...
LAST 30 PRESS RELEASES:
[Press-News.org] Further hope for BCG vaccine in stemming type 1 diabetes
Researchers presented positive trial updates at the 2021 Annual Scientific Sessions of the American Diabetes Association
